Eric Schoenmakers
Analyst-Equity at Point Sur Investors LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ramses Erdtmann | M | 60 |
Point Sur Investors LLC
 Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | 9 years |
| Tom Butler | M | 43 |
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | 9 years |
| Robert Duggan | M | 79 |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Manmeet Singh Soni | M | 46 |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | 3 years |
| Mahkam Zanganeh | M | 52 |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | 3 years |
| Richard van den Broek | M | 57 |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | 6 years |
| Katarzyna Szczepkowska | M | - |
Leuven University College
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 6 | 85.71% |
| Belgium | 1 | 14.29% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Schoenmakers
- Personal Network
